{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:12:01Z","timestamp":1790878321136,"version":"4.1.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["0098892"],"award-info":[{"award-number":["0098892"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neubiorev.2025.106310","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:51:06Z","timestamp":1753890666000},"page":"106310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Metabolomics: Potential non-protein biomarker candidates of Parkinson's disease"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0875-2912","authenticated-orcid":false,"given":"Michal","family":"Kaleta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"H\u00e9nykov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Men\u0161\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Kon\u00ed\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Ka\u0148ovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neubiorev.2025.106310_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1039\/D3AY01959D","article-title":"Analysis of tryptophan metabolites and related compounds in human and murine tissue: development and validation of a quantitative and semi-quantitative method using high resolution mass spectrometry","volume":"16","author":"Abujrais","year":"2024","journal-title":"Anal. Methods"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106310_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s13205-023-03553-8","article-title":"An update on pathogenesis and clinical scenario for Parkinson\u2019s disease: diagnosis and treatment","volume":"13","author":"Adam","year":"2023","journal-title":"3 Biotech"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib3","first-page":"4","article-title":"Metabolomics - an overview. From basic principles to potential biomarkers (part 1)","volume":"40","author":"Agin","year":"2016","journal-title":"M\u00e9d. Nucl."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10534-012-9525-y","article-title":"The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1","volume":"25","author":"Aguirre","year":"2012","journal-title":"Biometals"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/000456328802500319","article-title":"Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer","volume":"25","author":"Aldhous","year":"1988","journal-title":"Ann. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14521","article-title":"Sleep disorders cause parkinson's disease or the reverse is true: good GABA good night","volume":"30","author":"Al-kuraishy","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00210-023-02656-6","article-title":"Does vitamin d protect or treat parkinson's disease? A narrative review","volume":"397","author":"Al-kuraishy","year":"2024","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.neubiorev.2025.106310_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102200","article-title":"The classical and non-classical axes of renin-angiotensin system in parkinson disease: the bright and dark side of the moon","volume":"94","author":"Al-kuraishy","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106310_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18495","article-title":"The potential role of brain renin-angiotensin system in the neuropathology of parkinson disease: friend, foe or turncoat?","volume":"28","author":"Al-Qahtani","year":"2024","journal-title":"J. Cell Mol. Med."},{"issue":"27","key":"10.1016\/j.neubiorev.2025.106310_bib10","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1021\/acs.jpcb.5b04920","article-title":"N-Acetylserotonin and 6-hydroxymelatonin against oxidative stress: implications for the overall protection exerted by melatonin","volume":"119","author":"\u00c1lvarez-Diduk","year":"2015","journal-title":"J. Phys. Chem. B."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106310_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nbd.2004.03.014","article-title":"On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation","volume":"16","author":"Arriagada","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"19","key":"10.1016\/j.neubiorev.2025.106310_bib13","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.3390\/ijerph191912495","article-title":"Neurodegenerative diseases: implications of environmental and climatic influences on neurotransmitters and neuronal hormones activities","volume":"19","author":"Ayeni","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0748730417700458","article-title":"Daily rhythm in plasma N-acetyltryptamine","volume":"32","author":"Backlund","year":"2017","journal-title":"J. Biol. Rhythms"},{"key":"10.1016\/j.neubiorev.2025.106310_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson\u2019s disease and the environment","volume":"10","author":"Ball","year":"2019","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106310_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11306-018-1449-2","article-title":"Review of recent developments in GC-MS approaches to metabolomics-based research","volume":"14","author":"Beale","year":"2018","journal-title":"Metabolomics"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chom.2021.01.009","article-title":"Tryptophan metabolites get the gut moving","volume":"29","author":"Benech","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"21","key":"10.1016\/j.neubiorev.2025.106310_bib18","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1074\/jbc.M610893200","article-title":"Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein","volume":"282","author":"Bisaglia","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106310_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbadis.2010.06.006","article-title":"Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in parkinson disease","volume":"1802","author":"Bisaglia","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4103\/1673-5374.245464","article-title":"The metabolome identity: basis for discovery of biomarkers in neurodegeneration","volume":"14","author":"Bourgognon","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neubiorev.2025.106310_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jpba.2014.12.017","article-title":"Metabolomics for laboratory diagnostics","volume":"113","author":"Bujak","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6357","key":"10.1016\/j.neubiorev.2025.106310_bib22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in parkinson's disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2025.106310_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","article-title":"Axon degeneration in parkinson's disease","volume":"246","author":"Burke","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2025.106310_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2024.106528","article-title":"To what extent May aminochrome increase the vulnerability of dopaminergic neurons in the context of parkinson's disease","volume":"168","author":"Chagraoui","year":"2024","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106310_bib25","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1007\/s12035-017-0845-3","article-title":"Alternations of metabolic profile and kynurenine metabolism in the plasma of parkinson's disease","volume":"55","author":"Chang","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neubiorev.2025.106310_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577089","article-title":"Inflammasome and \u03b1-synuclein in parkinson's disease: a cross-sectional study","volume":"338","author":"Chatterjee","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106310_bib27","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/clinchem\/37.7.1178","article-title":"Rapid and specific enzyme immunoassay of serotonin","volume":"37","author":"Chauveau","year":"1991","journal-title":"Clin. Chem."},{"issue":"5545","key":"10.1016\/j.neubiorev.2025.106310_bib28","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106310_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/(SICI)1099-0801(199910)13:6<431::AID-BMC906>3.0.CO;2-O","article-title":"Determination of melatonin in pharmaceutical formulations and human plasma by gas chromatography-electron impact mass spectrometry","volume":"13","author":"Covaci","year":"1999","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/bbrc.2000.3087","article-title":"Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones","volume":"274","author":"Dagnino-Subiabre","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106310_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30452","article-title":"Diagnosing parkinson's disease and monitoring its progression: biomarkers from combined GC-TOF MS and LC-MS\/MS untargeted metabolomics","volume":"10","author":"Dahabiyeh","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neubiorev.2025.106310_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuro.2018.03.009","article-title":"Aminochrome decreases NGF, GDNF and induces neuroinflammation in organotypic midbrain slice cultures","volume":"66","author":"De Ara\u00fajo","year":"2018","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10571-021-01173-5","article-title":"Aminochrome induces neuroinflammation and dopaminergic neuronal loss: a new preclinical model to find anti-inflammatory and neuroprotective drugs for parkinson's disease","volume":"43","author":"De Ara\u00fajo","year":"2023","journal-title":"Cell Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-4165(02)00331-8","article-title":"Increased dopamine peroxidation in postmortem parkinsonian brain","volume":"1573","author":"De Iuliis","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0003-2697(72)90225-4","article-title":"A gas-liquid chromatographic assay of melatonin and indoleamines using heptafluorobutyryl derivatives","volume":"45","author":"Degen","year":"1972","journal-title":"Anal. Biochem."},{"issue":"5-7","key":"10.1016\/j.neubiorev.2025.106310_bib36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cem.941","article-title":"Symbiosis of chemometrics and metabolomics: past, present, and future","volume":"19","author":"van der Greef","year":"2005","journal-title":"J. Chemom."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","article-title":"Animal models of parkinson's disease: bridging the gap between disease hallmarks and research questions","volume":"12","author":"Dovonou","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neubiorev.2025.106310_bib38","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","article-title":"Cellular specificity of NF-\u03baB function in the nervous system","volume":"10","author":"Dresselhaus","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib39","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/clinchem\/28.4.624","article-title":"Radioimmunoassay of serotonin (5-hydroxytryptamine) in cerebrospinal fluid, plasma, and serum","volume":"28","author":"Engbaek","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.neubiorev.2025.106310_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2022.08.012","article-title":"Quantification of serotonin and eight of its metabolites in plasma of healthy volunteers by mass spectrometry","volume":"535","author":"Eugster","year":"2022","journal-title":"Clin. Chim. Acta"},{"issue":"10053","key":"10.1016\/j.neubiorev.2025.106310_bib41","first-page":"1545","volume":"388","author":"GBD","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106310_bib42","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-4159.1982.tb12565.x","article-title":"A single radioimmunological assay for serotonin, N-acetylserotonin, 5-methoxytryptamine, and melatonin","volume":"39","author":"Geffard","year":"1982","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106310_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2025.106310_bib44","series-title":"Biochemistry of Biogenic Amines.","first-page":"139","article-title":"Properties and functions of intraneuronal monoamine compartments in central aminergic neurons","author":"Glowinski","year":"1975"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/metabo12020194","article-title":"The potential of metabolomics in biomedical applications","volume":"12","author":"Gonzalez-Covarrubias","year":"2022","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106310_bib46","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/metabo10060229","article-title":"Recommendations and best practices for standardizing the pre-analytical processing of blood and uine samples in metabolomics","volume":"10","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2020","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106310_bib47","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/acssensors.9b01127","article-title":"Wearable electrochemical microneedle sensor for continuous monitoring of levodopa: toward parkinson management","volume":"4","author":"Goud","year":"2019","journal-title":"ACS Sens."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-079X.2009.00701.x","article-title":"Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines","volume":"47","author":"Hardeland","year":"2009","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","article-title":"Identification of novel biomarkers for parkinson's disease by metabolomic technologies","volume":"87","author":"Hatano","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106310_bib50","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.14104","article-title":"Changes in kynurenine pathway metabolism in parkinson patients with L-DOPA-induced dyskinesia","volume":"142","author":"Havelund","year":"2017","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106310_bib51","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.28202","article-title":"Tryptophan metabolites are associated with symptoms and nigral pathology in parkinson's disease","volume":"35","author":"Heilman","year":"2020","journal-title":"Mov. Dis."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"23","key":"10.1016\/j.neubiorev.2025.106310_bib53","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1021\/acschemneuro.2c00516","article-title":"Quantitative determination of endogenous tetrahydroisoquinolines, potential Parkinson\u2019s disease biomarkers, in mammals","volume":"13","author":"H\u00e9nykov\u00e1","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106310_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chroma.2016.02.009","article-title":"Stable isotope dilution ultra-high performance liquid chromatography-tandem mass spectrometry quantitative profiling of tryptophan-related neuroactive substances in human serum and cerebrospinal fluid","volume":"1437","author":"H\u00e9nykov\u00e1","year":"2016","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.neubiorev.2025.106310_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnana.2015.00032","article-title":"Inflammation in Parkinson\u2019s disease: role of glucocorticoids","volume":"9","author":"Herrero","year":"2015","journal-title":"Front. Neuroanat."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106310_bib56","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Movement disorder Society-endorsed PSP study group, 2017. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov. Dis."},{"key":"10.1016\/j.neubiorev.2025.106310_bib57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2019.00158","article-title":"Tryptophan metabolic pathways and brain serotonergic activity: a comparative review","volume":"10","author":"H\u00f6glund","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4161\/auto.27720","article-title":"Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction","volume":"10","author":"Huenchuguala","year":"2014","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib59","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1673-5374.380878","article-title":"Single-neuron neurodegeneration as a degenerative model for parkinson's disease","volume":"19","author":"Huenchuguala","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neubiorev.2025.106310_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134576","article-title":"Impaired metabolism of kynurenine and its metabolites in CSF of parkinson's disease","volume":"714","author":"Iwaoka","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2025.106310_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106441","article-title":"NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson\u2019s disease","volume":"83","author":"Javed","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2025.106310_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000520302","article-title":"Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid in parkinson's disease and atypical parkinsonian syndromes","volume":"21","author":"Kaiserova","year":"2021","journal-title":"Neurodegener. Dis."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib63","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1021\/acschemneuro.3c00611","article-title":"Patients with neurodegenerative proteinopathies exhibit altered tryptophan metabolism in the serum and cerebrospinal fluid","volume":"15","author":"Kaleta","year":"2024","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106310_bib64","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1365-2982.2009.01370.x","article-title":"Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function","volume":"21","author":"Keszthelyi","year":"2009","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib65","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41531-021-00239-x","article-title":"A six-metabolite panel as potential blood-based biomarkers for parkinson's disease","volume":"7","author":"Klatt","year":"2021","journal-title":"Npj Park. Dis."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106310_bib66","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/biomedicines10071760","article-title":"Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status","volume":"10","author":"Kon\u00ed\u010dkov\u00e1","year":"2022","journal-title":"Biomedicines"},{"issue":"18","key":"10.1016\/j.neubiorev.2025.106310_bib67","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.18-18-07111.1998","article-title":"Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons","volume":"18","author":"Kuhn","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106310_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1549549","article-title":"Role of inflammasomes in neuroimmune and neurodegenerative diseases: a systematic review","volume":"2018","author":"Lang","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106310_bib69","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","article-title":"Dopamine covalently modifies and functionally inactivates parkin","volume":"11","author":"LaVoie","year":"2005","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106310_bib70","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/mds.25555","article-title":"3-Hydroxykynurenine and other parkinson's disease biomarkers discovered by metabolomic analysis","volume":"28","author":"LeWitt","year":"2013","journal-title":"Mov. Disord."},{"issue":"4357","key":"10.1016\/j.neubiorev.2025.106310_bib71","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.675255","article-title":"Analysis of melatonin in human plasma by gas chromatography negative chemical ionization mass spectrometry","volume":"201","author":"Lewy","year":"1978","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib73","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbrc.2016.12.034","article-title":"Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro parkinson's disease models","volume":"482","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib74","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cell.2018.01.008","article-title":"Dopamine secretion is mediated by sparse active zone-like release sites","volume":"172","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2025.106310_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122938","article-title":"Simultaneous determination of melatonin and 6-hydroxymelatonin in human overnight urine by LC-MS\/MS","volume":"1181","author":"Magliocco","year":"2021","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib76","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s11064-017-2185-0","article-title":"The NLRP3 inflammasome is involved in the pathogenesis of Parkinson\u2019s disease in rats","volume":"42","author":"Mao","year":"2017","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib77","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/agm2.12243","article-title":"Neurodegenerative disorders: assessing the impact of natural vs drug-induced treatment options","volume":"6","author":"Mathur","year":"2023","journal-title":"Aging Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to alzheimer's disease: recommendations from The National institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-510X(97)00069-5","article-title":"Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with parkinson's disease","volume":"150","author":"Molina","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib81","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","article-title":"Interplay between cytosolic dopamine, calcium, and \u03b1-synuclein causes selective death of substantia nigra neurons","volume":"62","author":"Mosharov","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2025.106310_bib82","first-page":"161","article-title":"Commentary: evaluation of models of parkinson's disease","volume":"10","author":"Mu\u00f1oz","year":"2016","journal-title":"Front. Neurosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106310_bib83","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10787-022-01011-0","article-title":"Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action","volume":"30","author":"Mu\u00f1oz-Jurado","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib84","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nbd.2010.11.007","article-title":"Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of parkinson's disease","volume":"41","author":"Navailles","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2025.106310_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.826193","article-title":"Evidence that substantia nigra pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active","volume":"16","author":"Ni","year":"2022","journal-title":"Front. Cell Neurosci."},{"issue":"22","key":"10.1016\/j.neubiorev.2025.106310_bib86","doi-asserted-by":"crossref","first-page":"21212","DOI":"10.1074\/jbc.M412621200","article-title":"Reversible inhibition of \u03b1-synuclein fibrillization by dopaminochrome-mediated conformational alterations","volume":"280","author":"Norris","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106310_bib87","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1248\/cpb.c21-00982","article-title":"Development and validation of an LC-MS\/MS-based method for quantifying urinary endogenous 6-hydroxymelatonin","volume":"70","author":"Ohki","year":"2022","journal-title":"Chem. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib88","article-title":"Peripheral tryptophan - kynurenine metabolism associated with metabolic syndrome is different in parkinson's and alzheimer's diseases","volume":"1","author":"Oxenkrug","year":"2017","journal-title":"Endocrinol. Diabetes Metab. J."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib89","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12640-009-9148-4","article-title":"Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line","volume":"18","author":"Paris","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neubiorev.2025.106310_bib90","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/401264","article-title":"Oxidative stress and microglial cells in parkinson's disease","volume":"2012","author":"Peterson","year":"2012","journal-title":"Mediat. Inflamm."},{"issue":"6-8","key":"10.1016\/j.neubiorev.2025.106310_bib91","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0731-7085(88)80097-9","article-title":"Determination of tryptamine in rat brain by gas chromatography\u2014mass spectrometry","volume":"6","author":"Peura","year":"1988","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106310_bib92","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib93","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106310_bib94","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.36303\/SAJAA.2020.26.6.S3.2561","article-title":"Serotonin\/5-hydroxytryptamine (5-HT) physiology","volume":"26","author":"Redelinghuys","year":"2020","journal-title":"South Afr. J. Anaesth. Analg."},{"key":"10.1016\/j.neubiorev.2025.106310_bib95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.aca.2020.12.025","article-title":"Reviewing the metabolome coverage provided by LC-MS: focus on sample preparation and chromatography - a tutorial","volume":"1147","author":"Roca","year":"2021","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib96","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41531-021-00172-z","article-title":"Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase","volume":"7","author":"van Rumund","year":"2021","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.neubiorev.2025.106310_bib97","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tiv.2017.04.004","article-title":"Aminochrome induces microglia and astrocyte activation","volume":"42","author":"Santos","year":"2017","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.neubiorev.2025.106310_bib98","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","article-title":"Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson\u2019s disease","volume":"3","author":"Sarkar","year":"2017","journal-title":"Npj Park. Dis."},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106310_bib99","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41419-018-0798-0","article-title":"Can we conclude a potential therapeutic action for parkinson's disease by using postmortem tissue and a preclinical model based on an exogenous neurotoxin?","volume":"9","author":"Segura-Aguilar","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neubiorev.2025.106310_bib100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fnins.2018.00106","article-title":"Aminochrome induces irreversible mitochondrial dysfunction by inducing autophagy dysfunction in parkinson's disease","volume":"12","author":"Segura-Aguilar","year":"2018","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.neubiorev.2025.106310_bib101","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4103\/1673-5374.335690","article-title":"Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity","volume":"17","author":"Segura-Aguilar","year":"2022","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(98)00036-1","article-title":"Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase May play an important role in oxidative stress and apoptotic effects","volume":"1381","author":"Segura-Aguilar","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"issue":"24","key":"10.1016\/j.neubiorev.2025.106310_bib103","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.3390\/molecules26247565","article-title":"Application of the metabolomics approach in food authentication","volume":"26","author":"Selamat","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in parkinson's disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106310_bib105","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.neurobiolaging.2014.03.032","article-title":"Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in parkinson's disease","volume":"35","author":"Sikorska","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12626","article-title":"Characterization of serotonin and N-acetylserotonin systems in the human epidermis and skin cells","volume":"68","author":"Slominski","year":"2020","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib107","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5114\/reum.2015.53137","article-title":"Metabolomics and its potential in diagnosis, prognosis and treatment of rheumatic diseases","volume":"53","author":"Smole\u0144ska","year":"2015","journal-title":"Reumatologia"},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106310_bib108","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jnc.14843","article-title":"Age- and disease-specific changes of the kynurenine pathway in parkinson's and alzheimer's disease","volume":"151","author":"Sorgdrager","year":"2019","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib109","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jez.2554","article-title":"Cardiovascular serotonergic system: evolution, receptors, transporter, and function","volume":"337","author":"Soslau","year":"2022","journal-title":"J. Exp. Zool. A"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.114.218966","article-title":"Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus","volume":"351","author":"Stansley","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib111","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.12458","article-title":"Mechanism of NLRP3 inflammasome activation","volume":"1319","author":"Sutterwala","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib112","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp-2020-323520","article-title":"Fluid biomarkers in frontotemporal dementia: past, present and future","volume":"92","author":"Swift","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib113","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/glia.22762","article-title":"Redox regulation of NF-\u03baB p50 and M1 polarization in microglia","volume":"63","author":"Taetzsch","year":"2015","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib114","article-title":"Correlation between serum RANTES levels and the severity of Parkinson\u2019s disease","volume":"2014","author":"Tang","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0304-3940(93)90111-W","article-title":"Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms","volume":"150","author":"Tohgi","year":"1993","journal-title":"Neurosci. Lett."},{"issue":"1-2","key":"10.1016\/j.neubiorev.2025.106310_bib116","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3940(93)90817-5","article-title":"Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with parkinson's disease, and their changes after L-dopa administration","volume":"159","author":"Tohgi","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2025.106310_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113246","article-title":"A validated UHPLC-MS method for tryptophan metabolites: application in the diagnosis of multiple sclerosis","volume":"185","author":"T\u00f6m\u00f6si","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm00223a008","article-title":"Potential oxidative pathways of brain catecholamines","volume":"19","author":"Tse","year":"1976","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib119","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3945\/ajcn.113.064998","article-title":"Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status","volume":"98","author":"Ulvik","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nbd.2009.03.004","article-title":"Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells","volume":"34","author":"Van Laar","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neubiorev.2025.106310_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102287","article-title":"Metabolomic profiling reveals bacterial metabolic adaptation strategies and new metabolites","volume":"74","author":"Wang","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106310_bib122","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1046\/j.1471-4159.2001.00125.x","article-title":"Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter","volume":"76","author":"Whitehead","year":"2001","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib123","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s007020200014","article-title":"Increased neopterin production and tryptophan degradation in advanced parkinson's disease","volume":"109","author":"Widner","year":"2002","journal-title":"J. Neural Transm."},{"issue":"D1","key":"10.1016\/j.neubiorev.2025.106310_bib124","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the human metabolome database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neubiorev.2025.106310_bib125","first-page":"619","article-title":"Microglia in physiology and disease","volume":"79","author":"Wolf","year":"2017","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neubiorev.2025.106310_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1040434","article-title":"How to employ metabolomic analysis to research on functions of prebiotics and probiotics in poultry gut health?","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib127","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41531-022-00402-y","article-title":"Mitophagy and reactive oxygen species interplay in parkinson's disease","volume":"8","author":"Xiao","year":"2022","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.neubiorev.2025.106310_bib128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2121-11-89","article-title":"Acetylated microtubules are required for fusion of autophagosomes with lysosomes","volume":"11","author":"Xie","year":"2010","journal-title":"BMC Cell Biol."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.taap.2014.08.014","article-title":"Quinone-induced protein handling changes: implications for major protein handling systems in quinone-mediated toxicity","volume":"280","author":"Xiong","year":"2014","journal-title":"Toxicol. Appl. Pharm."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106310_bib130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/ijms18020389","article-title":"Vanillin protects dopaminergic neurons against inflammation-mediated cell death by inhibiting ERK1\/2, P38 and the NF-\u03baB signaling pathway","volume":"18","author":"Yan","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib131","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/mol.106.024703","article-title":"A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition","volume":"70","author":"Zafar","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106310_bib132","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","article-title":"The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in parkinson's disease","volume":"510","author":"Zecca","year":"2002","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib133","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neubiorev.2025.106310_bib134","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpba.2015.09.028","article-title":"A novel LC-MS\/MS assay for the simultaneous determination of melatonin and its two major metabolites, 6-hydroxymelatonin and 6-sulfatoxymelatonin in dog plasma: application to a pharmacokinetic study","volume":"117","author":"Zhao","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106310_bib135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/iub.2654","article-title":"Neuromelanins in brain aging and parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role","volume":"75","author":"Zucca","year":"2023","journal-title":"IUBMB Life"},{"key":"10.1016\/j.neubiorev.2025.106310_bib136","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-nutr-120420-021719","article-title":"Sleep and diet: mounting evidence of a cyclical relationship","volume":"41","author":"Zuraikat","year":"2021","journal-title":"Annu. Rev. Nutr."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425003112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425003112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:11:17Z","timestamp":1772784677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425003112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":136,"alternative-id":["S0149763425003112"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106310","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomics: Potential non-protein biomarker candidates of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106310"}}